All Publications
Filter
Prade, V.M. ; Gundlach, H. ; Twardziok, S.O. ; Chapman, B. ; Tan, C.S. ; Langridge, P. ; Schulman, A.H. ; Stein, N. ; Waugh, R. ; Zhang, G. ; Platzer, M. ; Li, C. ; Spannagl, M. ; Mayer, K.F.X.
The pseudogenes of barley.Ingold, I. ; Berndt, C. ; Schmitt, S. ; Doll, S. ; Poschmann, G. ; Roveri, A. ; Peng, X. ; Freitas, F.P. ; Aichler, M. ; Jastroch, M. ; Ursini, F. ; Arner, E.S.J. ; Fradejas-Villar, N. ; Schweizer, U. ; Zischka, H. ; Friedmann Angeli, J.P.F. ; Conrad, M.
Selenium utilization by GPX4 was an evolutionary requirement to prevent hydroperoxide-induced ferroptosis.Klaeger, S. ; Heinzlmeir, S. ; Wilhelm, M. ; Polzer, H. ; Vick, B. ; Koenig, P.A. ; Reinecke, M. ; Ruprecht, B. ; Petzoldt, S. ; Meng, C. ; Zecha, J. ; Reiter, K. ; Qiao, H. ; Helm, D. ; Koch, H. ; Schoof, M. ; Canevari, G. ; Casale, E. ; Depaolini, S.R. ; Feuchtinger, A. ; Wu, Z. ; Schmidt, T. ; Rueckert, L. ; Becker, W. ; Huenges, J. ; Garz, A.K. ; Gohlke, B.O. ; Zolg, D.P. ; Kayser, G. ; Vooder, T. ; Preissner, R. ; Hahne, H. ; Tõnisson, N. ; Kramer, K. ; Götze, K. ; Bassermann, F. ; Schlegl, J. ; Ehrlich, H.C. ; Aiche, S. ; Walch, A.K. ; Greif, P.A. ; Schneider, S. ; Felder, E.R. ; Ruland, J. ; Médard, G. ; Jeremias, I. ; Spiekermann, K. ; Kuster, B.
The target landscape of clinical kinase drugs.Rodriguez Camargo, D.C. ; Korshavn, K.J. ; Jussupow, A. ; Raltchev, K. ; Goricanec, D. ; Fleisch, M. ; Sarkar, R. ; Xue, K. ; Aichler, M. ; Mettenleiter, G. ; Walch, A.K. ; Camilloni, C. ; Hagn, F. ; Reif, B. ; Ramamoorthy, A.
Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate.Desbenoit, N. ; Walch, A.K. ; Spengler, B. ; Brunelle, A. ; Römpp, A.
Correlative mass spectrometry imaging, applying TOF-SIMS and AP-MALDI to a single tissue section.Jacobs, L. ; Habringer, S. ; Slawska, J. ; Huber, K. ; Hauf, E. ; Li, Z. ; Refaeli, Y. ; Schwaiger, M. ; Rudelius, M. ; Walch, A.K. ; Keller, U.
Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma.Gary, R. ; Aigner, M. ; Moosmann, A. ; Moi, S. ; Schaffer, S. ; Balzer, H.J. ; Maas, S. ; Strobel, J. ; Zimmermann, R. ; Zingsem, J. ; Kremer, A. ; Meintker, L. ; Mackensen, A. ; Gerbitz, A.
Adoptive transfer of CMV- and EBV-specific peptide-stimulated T cells after allogeneic stem cell transplantation: First results of a phase I/IIa clinical trial [AIT-MULTIVIR-01].Richter, A.S. ; Roolf, C. ; Sender, S. ; Sekora, A. ; Knbel, G. ; Vollmar, B. ; Jeremias, I. ; Escobar, M.H. ; Junghanss, C.
CK2 inhibition reduces cell proliferation in acute B-lymphoblastic leukemia cells in vitro and in vivo.Urban, C. ; Buck, A. ; Siveke, J.T. ; Lordick, F. ; Luber, B. ; Walch, A.K. ; Aichler, M.
PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSI.Mümmler, C. ; Burgy, O. ; Hermann, S. ; Mutze, K. ; Günther, A. ; Königshoff, M.
Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.Glaser, L.V. ; Rieger, S. ; Thumann, S. ; Beer, S. ; Kuklik-Roos, C. ; Martin, D.E. ; Maier, K.C. ; Harth-Hertle, M.L. ; Grüning, B. ; Backofen, R. ; Krebs, S. ; Blum, H. ; Zimmer, R. ; Erhard, F. ; Kempkes, B.
EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.Fichter, C.D. ; Przypadlo, C.M. ; Buck, A. ; Herbener, N. ; Riedel, B. ; Schäfer, L. ; Nakagawa, H. ; Walch, A.K. ; Reinheckel, T. ; Werner, M. ; Lassmann, S.
A new model system identifies EGFR/HER2 and HER2/HER3 heterodimers as potent inducers of oesophageal epithelial cell invasion.Link, E.K. ; Brandmüller, C. ; Suezer, Y. ; Ameres, S. ; Volz, A. ; Moosmann, A. ; Sutter, G. ; Lehmann, M.H.
A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.Ayoubian, H. ; Fröhlich, T. ; Pogodski, D. ; Flatley, A. ; Kremmer, E. ; Schepers, A. ; Feederle, R. ; Arnold, G.J. ; Grässer, F.A.
Antibodies against the mono-methylated arginine-glycine repeat (MMA-RG) of the Epstein-Barr virus nuclear antigen 2 (EBNA2) identify potential cellular proteins targeted in viral transformation.Koch, M. ; de Jong, J.S. ; Glatz, J. ; Symvoulidis, P. ; Lamberts, L.E. ; Adams, A.L.L. ; Kranendonk, M.E.G. ; van Scheltinga, A.T. ; Aichler, M. ; Jansen, L. ; de Vries, J. ; Lub-de Hooge, M. ; Schröder, C.P. ; Jorritsma-Smit, A. ; Linssen, M.D. ; de Boer, E. ; van der Vegt, B. ; Nagengast, W.B. ; Elias, S.G. ; Oliveira, S. ; Witkamp, A.J. ; Mali, W.P.Th.M. ; van der Wall, E. ; Garcia-Allende, P. ; van Diest, P.J. ; de Vries, E.G. ; Walch, A.K. ; van Dam, G.M. ; Ntziachristos, V.
Fluorescently labeled bevacizumab in human breast cancer: Defining the classification threshold.Brustel, J. ; Kirstein, N. ; Izard, F. ; Grimaud, C. ; Prorok, P. ; Cayrou, C. ; Schotta, G. ; Abdelsamie, A.S. ; Déjardin, J. ; Méchali, M. ; Baldacci, G. ; Sardet, C. ; Cadoret, J.C. ; Schepers, A. ; Julien, E.
Histone H4K20 tri-methylation at late-firing origins ensures timely heterochromatin replication.Schlecht, A. ; Leimbeck, S.V. ; Jägle, H. ; Feuchtinger, A. ; Tamm, E.R. ; Braunger, B.M.
Deletion of endothelial TGF-β signaling leads to choroidal neovascularization.Yang, F. ; Aubele, M. ; Walch, A.K. ; Gross, E. ; Napieralski, R. ; Zhao, S. ; Ahmed, N. ; Kiechle, M. ; Reuning, U. ; Dorn, J. ; Sweep, F.C. ; Magdolen, V. ; Schmitt, M.
Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer.Kunzke, T. ; Balluff, B. ; Feuchtinger, A. ; Buck, A. ; Langer, R. ; Luber, B. ; Lordick, F. ; Zitzelsberger, H. ; Aichler, M. ; Walch, A.K.
Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome.Lichtenegger, F.S. ; Deiser, K. ; Rothe, M. ; Krupka, C. ; Schnorfeil, F.M. ; Augsberger, C. ; Koehnke, T. ; Buecklein, V. ; Altmann, T. ; Moosmann, A. ; Brueggemann, M. ; Heemskerk, M.H.M. ; Wagner, B. ; Hiddemann, W. ; Bigalke, I. ; Kvalheitn, G. ; Subklewe, M.
Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: Results of a phase I/II trial and ex vivo enhancement by checkpoint blockade.Loebel, M. ; Eckey, M. ; Sotzny, F. ; Hahn, E.G. ; Bauer, S. ; Grabowski, P. ; Zerweck, J. ; Holenya, P. ; Hanitsch, L.G. ; Wittke, K. ; Borchmann, P. ; Rüffer, J.U. ; Hiepe, F. ; Ruprecht, K. ; Behrends, U. ; Meindl, C. ; Volk, H.D. ; Reimer, U. ; Scheibenbogen, C.
Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Albanese, M. ; Tagawa, T. ; Buschle, A. ; Hammerschmidt, W.
MicroRNAs of Epstein-Barr virus control innate and adaptive anti-viral immunity.Heckl, B. ; Carlet, M. ; Grunert, M. ; Vick, B. ; Roolf, C. ; Junghanss, C. ; Spiekermann, K. ; Hiddemann, W. ; Jeremias, I.
Adult primary acute leukemia samples with chromosomal translocations grow well in immunodeficient mice, but are difficult to transduce with lentiviruses.Altamura, S. ; Vegi, N. ; Hueltner, L. ; Schneider, M. ; Höppe, P. ; Schroeder, T. ; Canli, Ö. ; Greten, F.R. ; Aichler, M. ; Walch, A.K. ; Neff, F. ; Janik, D. ; Kuklik-Roos, C. ; Ladinig, C. ; Mysliwietz, J. ; Rathkolb, B. ; Buske, C. ; Conrad, M. ; Muckenthaler, M.U. ; Bornkamm, G.W.
Lack of the ferroptosis inhibitor GPX4 in erythroid cells causes a block in reticulocyte maturation and a hypoxic signature with impaired hepcidin regulation.Düwel, S. ; Hundshammer, C. ; Gersch, M. ; Feuerecker, B. ; Steiger, K. ; Buck, A. ; Walch, A.K. ; Haase, A. ; Glaser, S.J. ; Schwaiger, M. ; Schilling, F.
Imaging of pH in vivo using hyperpolarized 13C-labelled zymonic acid.Hachmöller, O. ; Aichler, M. ; Schwamborn, K. ; Lutz, L. ; Werner, M. ; Sperling, M. ; Walch, A.K. ; Karst, U.
Investigating the influence of standard staining procedures on the copper distribution and concentration in Wilson's disease liver samples by laser ablation-inductively coupled plasma-mass spectrometry.David, A. ; Arnaud, N. ; Fradet, M. ; Lascaux, H. ; Ouk-Martin, C. ; Gachard, N. ; Zimber-Strobl, U. ; Feuillard, J. ; Faumont, N.
c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.Medina, A.M. ; Vierkotten, S. ; Lehmann, M. ; Wagner, D. ; Baarsma, H. ; Höfer, T. ; Frankerberger, M. ; Behr, J. ; Aichler, M. ; Walch, A. ; Königshoff, M.
Wnt5a is secreted by extracellular vesicles in pulmonary fibrosis and increases fibroblasts proliferation.Aichler, M. ; Borgmann, D.M. ; Krumsiek, J. ; Buck, A. ; MacDonald, P.E. ; Fox, J.E.M. ; Lyon, J. ; Light, P.E. ; Keipert, S. ; Jastroch, M. ; Feuchtinger, A. ; Müller, N.S. ; Sun, N. ; Palmer, A. ; Alexandrov, T. ; Hrabě de Angelis, M. ; Neschen, S. ; Tschöp, M.H. ; Walch, A.K.
N-acyl taurines and acylcarnitines cause an imbalance in insulin synthesis and secretion provoking β cell dysfunction in type 2 diabetes.Barthels, C. ; Ogrinc, A. ; Steyer, V. ; Meier, S. ; Simon, F. ; Wimmer, M. ; Blutke, A. ; Straub, T. ; Zimber-Strobl, U. ; Lutgens, E. ; Marconi, P. ; Ohnmacht, C. ; Garzetti, D. ; Stecher, B. ; Brocker, T.
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis.Feederle, R. ; Schepers, A.
Antibodies specific for nucleic acid modifications.Arlt, W. ; Lang, K. ; Sitch, A.J. ; Dietz, A.S. ; Rhayem, Y. ; Bancos, I. ; Feuchtinger, A. ; Chortis, V. ; Gilligan, L.C. ; Ludwig, P. ; Riester, A. ; Asbach, E. ; Hughes, B.A. ; O'Neil, D.M. ; Bidlingmaier, M. ; Tomlinson, J.W. ; Hassan-Smith, Z.K. ; Rees, D.A. ; Adolf, C. ; Hahner, S. ; Quinkler, M. ; Dekkers, T. ; Deinum, J. ; Biehl, M. ; Keevil, B.G. ; Shackleton, C.H.L. ; Deeks, J.J. ; Walch, A.K. ; Beuschlein, F. ; Reincke, M.
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism.Finkenzeller, C. ; Carlet, M. ; Vosberg, S. ; Neumann, M. ; Riecken, K. ; Cornils, K. ; Fehse, B. ; Baldus, C.D. ; Greif, P.A. ; Jeremias, I.
Clones with and without sensitivity towards treatment in vivo co-exist within a single sample of a patient with ALL.Vergalli, J. ; Carlet, M. ; Hoffmann, T. ; Roth, M. ; Zuber, J. ; Jeremias, I.
XIAP is an attractive therapeutic target for all as validated in innovative genetically rngineered patient-derived xenograft models.Koczian, F. ; Vomacka, J. ; Vick, B. ; Hettich, B. ; Kazmaier, U. ; Sieber, S.A. ; Jeremias, I. ; Vollmar, A. ; Braig, S.
Targeting the ER-mitochondrial interface of cell death sensitizes leukemia cells towards cytostatics.Vick, B. ; Holdt, L.M. ; Hiddemann, W.R. ; Spiekermann, K. ; Jeremias, I.
Modeling AML standard induction chemotherapy in the PDX mouse model.Heckl, B. ; Carlet, M. ; Grunert, M. ; Vick, B. ; Roolf, C. ; Junghanss, C. ; Spiekermann, K. ; Hiddemann, W.R. ; Jeremias, I.
Primary adult acute lymphoblastic leukemic cells reliably engraft and grow in immunodeficient mice.Oezdemir, E. ; Ziegenhain, C. ; Panzer-Gruenmayer, R. ; Enard, W. ; Jeremias, I.
A preclinical PDX model for patients` minimal residual disease in ALL.Ebinger, S. ; Liu, W. ; Tiedt, S. ; Alves, C.C. ; Jeremias, I.
A rare population of drug resistant, dormant stem cells exists in patients' acute lymphoblastic leukemia growing in mice.Bagnoli, J. ; Ziegenhain, C. ; Vieth, B. ; Parekh, S. ; Vick, B. ; Jeremias, I. ; Hellmann, I. ; Enard, W.
Transcriptional heterogeneity in AML - evolution of gene expression in patient derived xenografts.Valtierra-Gutierrez, I.A. ; Farre-Orteu, A. ; Richter, M. ; Greif, P.A. ; Ziegenhain, C. ; Jeremias, I. ; Metzeler, K. ; Spiekermann, K. ; Enard, W. ; Hellmann, I.
Detection of single-nucleotide variants in acute myeloid leukemia (AML) from bulk and single-cell RNA sequencing.Van Deun, J. ; Mestdagh, P. ; Agostinis, P. ; Akay, Ö. ; Anand, S. ; Anckaert, J. ; Martinez, Z.A. ; Baetens, T. ; Beghein, E. ; Bertier, L. ; Berx, G. ; Boere, J. ; Boukouris, S. ; Bremer, M. ; Buschmann, D. ; Byrd, J.B. ; Casert, C. ; Cheng, L. ; Cmoch, A. ; Daveloose, D. ; De Smedt, E. ; Demirsoy, S. ; Depoorter, V. ; Dhondt, B. ; Driedonks, T.A.P. ; Dudek, A. ; Elsharawy, A. ; Floris, I. ; Foers, A.D. ; Gärtner, K. ; Garg, A.D. ; Geeurickx, E. ; Gettemans, J. ; Ghazavi, F. ; Giebel, B. ; Kormelink, T.G. ; Hancock, G. ; Helsmoortel, H. ; Hill, A.F. ; Hyenne, V. ; Kalra, H. ; Kim, D. ; Kowal, J. ; Kraemer, S. ; Leidinger, P. ; Leonelli, C. ; Liang, Y. ; Lippens, L. ; Liu, S. ; Lo Cicero, A. ; Martin, S. ; Mathivanan, S. ; Mathiyalagan, P. ; Matusek, T. ; Milani, G. ; Monguió-Tortajada, M. ; Mus, L.M. ; Muth, D.C. ; Németh, A. ; Nolte-'T Hoen, E.N.M. ; O'Driscoll, L. ; Palmulli, R. ; Pfaffl, M.W. ; Primdal-Bengtson, B. ; Romano, E. ; Rousseau, Q. ; Sahoo, S. ; Sampaio, N. ; Samuel, M.A. ; Scicluna, B.P. ; Soen, B. ; Steels, A. ; Swinnen, J.V. ; Takatalo, M. ; Thaminy, S. ; Théry, C. ; Tulkens, J. ; Van Audenhove, I. ; Van Der Grein, S. ; Van Goethem, A. ; Van Herwijnen, M.J. ; Van Niel, G. ; Van Roy, N. ; Van Vliet, A.R. ; Vandamme, N. ; Vanhauwaert, S. ; Vergauwen, G. ; Verweij, F.
EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research.Knüppel, L. ; Ishikawa, Y. ; Aichler, M. ; Heinzelmann, K. ; Hatz, R. ; Behr, J. ; Walch, A.K. ; Bächinger, H.P. ; Eickelberg, O. ; Staab-Weijnitz, C.A.
A novel antifibrotic mechanism of nintedanib and pirfenidone: Inhibition of collagen fibril assembly.Dislich, B. ; Stein, A. ; Seiler, C.A. ; Kröll, D. ; Berezowska, S. ; Zlobec, I. ; Galvan, J.A. ; Slotta-Huspenina, J. ; Walch, A.K. ; Langer, R.
Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: Comparison between primary tumors and metastases.Echtler, K. ; Konrad, I. ; Lorenz, M. ; Schneider, S. ; Hofmaier, S. ; Plenagl, F. ; Stark, K. ; Czermak, T. ; Tirniceriu, A. ; Eichhorn, M.E. ; Walch, A.K. ; Enders, G. ; Massberg, S. ; Schulz, C.
Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.Rodriguez Camargo, D.C. ; Tripsianes, K. ; Buday, K. ; Frankó, A. ; Göbl, C. ; Hartlmüller, C. ; Sarkar, R. ; Aichler, M. ; Mettenleiter, G. ; Schulz, M. ; Böddrich, A. ; Erck, C. ; Martens, H. ; Walch, A.K. ; Madl, T. ; Wanker, E.E. ; Conrad, M. ; Hrabě de Angelis, M. ; Reif, B.
The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes.Schober, T. ; Magg, T. ; Laschinger, M. ; Rohlfs, M. ; Linhares, N.D. ; Puchalka, J. ; Weisser, T. ; Fehlner, K. ; Mautner, J. ; Walz, C. ; Hussein, K. ; Jaeger, G. ; Kammer, B. ; Schmid, I. ; Bahia, M. ; Pena, S.D.J. ; Behrends, U. ; Belohradsky, B.H. ; Klein, C. ; Hauck, F.
A human immunodeficiency syndrome caused by mutations in CARMIL2.Shumilov, A. ; Tsai, M.H. ; Schlosser, Y.T. ; Kratz, A.S. ; Bernhardt, K. ; Fink, S. ; Mizani, T. ; Lin, X. ; Jauch, A. ; Mautner, J. ; Kopp-Schneider, A. ; Feederle, R. ; Hoffmann, I. ; Delecluse, H.J.
Epstein-Barr virus particles induce centrosome amplification and chromosomal instability.Frankó, A. ; Neschen, S. ; Rozman, J. ; Rathkolb, B. ; Aichler, M. ; Feuchtinger, A. ; Brachthäuser, L. ; Neff, F. ; Kovarova, M. ; Wolf, E. ; Fuchs, H. ; Häring, H.-U. ; Peter, A. ; Hrabě de Angelis, M.
Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.Ghosh, S. ; Hönscheid, A. ; Dückers, G. ; Ginzel, S. ; Gohlke, H. ; Gombert, M. ; Kempkes, B. ; Klapper, W. ; Kuhlen, M. ; Laws, H.J. ; Linka, R.M. ; Meisel, R. ; Niehues, T. ; Schindler, D. ; Schuster, F.R. ; Speckmann, C. ; Borkhardt, A.
Human RAD52: a novel player in DNA repair in cancer and immunodeficiency.Buck, A. ; Aichler, M. ; Huber, K. ; Walch, A.K.
In situ metabolomics in cancer by mass spectrometry imaging.Göllner, S. ; Oellerich, T. ; Agrawal-Singh, S. ; Schenk, T. ; Klein, H. ; Rohde, C. ; Pabst, C. ; Sauer, T. ; Lerdrup, M. ; Tavor, S. ; Stoelzel, F. ; Herold, S. ; Ehninger, G. ; Koehler, G. ; Pan, K. ; Urlaub, H. ; Serve, H. ; Dugas, M. ; Spiekermann, K. ; Vick, B. ; Jeremias, I. ; Berdel, W.E. ; Hansen, K. ; Zelent, A. ; Wickenhauser, C. ; Mueller, L.P. ; Thiede, C. ; Mueller-Tidow, C.
Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.Ma, X. ; van Phi, V. ; Kimm, M.A. ; Prakash, J. ; Kessler, H. ; Kosanke, K. ; Feuchtinger, A. ; Aichler, M. ; Gupta, A. ; Rummeny, E.J. ; Eisenblätter, M. ; Siveke, J. ; Walch, A.K. ; Braren, R. ; Ntziachristos, V. ; Wildgruber, M.
Integrin-targeted hybrid fluorescence molecular tomography/X-ray computed tomography for imaging tumor progression and early response in non-small cell lung cancer.Zhao, S. ; Dorn, J. ; Napieralski, R. ; Walch, A.K. ; Diersch, S. ; Kotzsch, M. ; Ahmed, N. ; Hooper, J. ; Kiechle, M. ; Schmitt, M. ; Magdolen, V.
Plasmin(Ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer.Koch, M. ; de Jong, J.S. ; Glatz, J. ; Symvoulidis, P. ; Lamberts, L.E. ; Adams, A.L.L. ; Kranendonk, M.E.G. ; Terwisscha van Scheltinga, A.G. ; Aichler, M. ; Jansen, L. ; de Vries, J. ; Lub-de, Hoog, M.N. ; Schröder, C.P. ; Jorritsma-Smit, A. ; Linssen, M.D. ; de Boer, E. ; van der Vegt, B. ; Nagengast, W.B. ; Elisas,S.G. ; Oliveira, S. ; Witkamp, A.J. ; Mali, W.P.Th.M. ; van der Wall, E. ; Gracia-Allende, P.B. ; van Diest, P.J. ; de Vries, E.G. ; Walch, A.K. ; van Dam, G.M. ; Ntziachristos, V.
Threshold analysis and biodistribution of fluorescently labeled bevacizumab in human breast cancer.Doll, S. ; Proneth, B. ; Tyurina, A.A. ; Panzilius, E. ; Kobayashi, S. ; Ingold, I. ; Irmler, M. ; Beckers, J. ; Aichler, M. ; Walch, A.K. ; Prokisch, H. ; Trümbach, D. ; Mao, G. ; Qu, F. ; Bayir, H. ; Füllekrug, J. ; Scheel, C. ; Wurst, W. ; Schick, J. ; Kagan, V.E. ; Friedmann Angeli, J.P.F. ; Conrad, M.
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.